This is a comprehensive examination of the body aimed at the early detection, monitoring, and assessment of the spread of tumors and metastases.

CT is the only imaging method that provides high-quality evaluation of the lungs, which is why it is so widely used in oncological practice.

The procedure is performed both for monitoring cancer treatment, staging, and assessing response to therapy, and for preventive screening in healthy individuals who are at increased risk, wish to exclude oncological diseases, or may have tumors at asymptomatic stages.

CT screening images allow assessment of the organs of the chest, abdomen, and pelvis. Computed tomography is one of the best methods for early diagnosis, as it can detect lesions as small as 1 mm.

In addition to detecting tumors, CT makes it possible to perform cancer staging (determining the extent of the disease), which helps physicians choose the most appropriate treatment strategy.

Indications for Oncologic Screening

Oncologic CT screening is generally recommended every 1 to 1.5 years. According to WHO statistics, treatment of stage I cancer is successful in 93% of cases. Patients with stage II cancer survive in 75% of cases, while stage IV survival reaches approximately 45%. CT oncologic screening is especially recommended for patients with:

• a significant family history of cancer;
• harmful habits, including smoking;
• benign tumors;
• age over 35 years;
• chronic stress.

Screening is strongly recommended for anyone who has been experiencing the following symptoms for a prolonged period:

• general malaise;
• rapid fatigue;
• elevated body temperature;
• nausea and dry mouth;
• sudden weight loss;
• unusual sensations;
• the appearance of lumps or masses in the skin or body that can be seen or felt.